Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
European Journal of Heart Failure
|
August 21, 2014
Impaired left atrial function in heart failure with preserved ejection fraction
Angela B S Santos, Elisabeth Kraigher-Krainer, Deepak K Gupta, et al.
European Heart Journal
|
May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S Desai, John J V McMurray, Milton Packer, et al.
European Journal of Heart Failure
|
January 6, 2022
Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure
Finnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
Circulation
|
August 27, 2020
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction
Finnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
Circulation. Heart Failure
|
March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis
Luis E Rohde, Brian L Claggett, Emil Wolsk, et al.
JACC. Heart Failure
|
July 11, 2021
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial
Mauro Gori, Michele Senni, Brian Claggett, et al.
Circulation
|
November 19, 2019
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
European Journal of Heart Failure
|
December 12, 2018
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas
Pooja Dewan, Pardeep S Jhund, Li Shen, et al.
European Heart Journal
|
November 23, 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
John McMurray, Milton Packer, Akshay Desai, et al.
Circulation. Heart Failure
|
March 31, 2017
Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations
Javed Butler, Carine E Hamo, James E Udelson, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
European Journal of Heart Failure
|
August 21, 2014
Impaired left atrial function in heart failure with preserved ejection fraction
Angela B S Santos, Elisabeth Kraigher-Krainer, Deepak K Gupta, et al.
European Heart Journal
|
May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S Desai, John J V McMurray, Milton Packer, et al.
European Journal of Heart Failure
|
January 6, 2022
Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure
Finnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
Circulation
|
August 27, 2020
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction
Finnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
Circulation. Heart Failure
|
March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis
Luis E Rohde, Brian L Claggett, Emil Wolsk, et al.
JACC. Heart Failure
|
July 11, 2021
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial
Mauro Gori, Michele Senni, Brian Claggett, et al.
Circulation
|
November 19, 2019
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
European Journal of Heart Failure
|
December 12, 2018
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas
Pooja Dewan, Pardeep S Jhund, Li Shen, et al.
European Heart Journal
|
November 23, 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
John McMurray, Milton Packer, Akshay Desai, et al.
Circulation. Heart Failure
|
March 31, 2017
Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations
Javed Butler, Carine E Hamo, James E Udelson, et al.
Page
of 7